AI vs MRI for spotting lymph node spread in cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares an AI prediction model to standard MRI imaging to see which better identifies if cervical cancer has spread to lymph nodes. It aims to improve accuracy and help guide treatment decisions for women with early- to mid-stage cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer (Stage I, II, or III) and are scheduled for a radical hysterectomy with pelvic lymph node removal.
- You are between 18 and 80 years old.
- You had a pelvic MRI (with or without contrast) at the study hospital or a partner center within one month before surgery.
- You have not received chemotherapy or radiation before surgery for this cancer.
- You are not pregnant, breastfeeding, or had a miscarriage in the last 42 days.
- You have not had other cancers in the last 5 years (except possibly non-melanoma skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new artificial intelligence (AI) system to detect cervical cancer from images taken during a colposcopy exam. If successful, it could help doctors identify cancer earlier and more accurately.
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
This study uses artificial intelligence to analyze your preoperative MRI and pathology results to better predict if cervical cancer has spread to pelvic lymph nodes. The goal is to improve future treatment decisions for patients with cervical cancer.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This trial tests whether a computer model can accurately detect if cancer has spread to lymph nodes in patients with nasopharyngeal carcinoma. It uses MRI and PET/CT scans taken before treatment to see if the AI can replace or supplement current methods.
Hear when a new Uterine Cervical Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.